NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Since then, the MHRA has considered the success of dc-vax for other types of cancer being treated under compassionate care and started working with NWBO to expand the scope beyond just for glioblastoma.

That is not how the process works. Additional indications are added via Variations (or sBLA/sNDA for the FDA).

They will use Sl87 to justify this.

That says noting at all about this. What it allows is for a company to set up additional mfg sites under domain of a main, GMP approved, mfg site with much less work. NWBO presently has a single mfg site.

The submission was under the old manufacturing process, but they upped the scope to include flaskworks and advent as the same source allowing for flaskworks to be phased

NWBO has not yet had prototype GMP Eden devices built. And they have a lot of testing to do before they can submit that to the MHRA,

Am I getting it so far?

Yup.